Chapter 90: Drugs That Weaken the Bacterial Cell Wall II: Other Drugs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine surviving a massive, life -threatening infection and finally feeling like you are out of the woods.

Right.

The worst is over.

Exactly.

Only to discover that the, well, the quote -unquote miracle drug that just saves your life has actually triggered a completely different, equally deadly disease right in your gut.

Yeah, that is the grand paradox of modern antibiotics.

I mean, we are talking about medications powerful enough to literally blow up bacterial cells.

But they're clumsy,

like clumsy enough to just wipe out the invisible ecosystems keeping you healthy.

Exactly.

And today we are looking at the heavy hitters.

So if you're a nursing student listening right now, prepping for an exam or a clinical rotation, your mission today is to master Chapter 90.

Right.

From Lanny's pharmacology, the drugs that weaken the bacterial cell wall.

But not penicillins.

We covered those.

Yeah.

We are going way beyond penicillins today to the other cell wall wreckers.

You know, the broad spectrum bombs, the highly targeted snipers and those specialized tools you're going to see every single day at the bedside.

And the overarching rule for our deep dive today is pretty simple.

We aren't just memorizing a list of complicated drug names.

That doesn't help anyone.

No, not at all.

We are going to figure out the underlying mechanisms.

Like the exact biological reasons why you, the nurse actually standing at the bedside, need to monitor specific labs or adjust IV infusion rates or even change how you wash your hands.

So to understand these drugs, you first really have to visualize what they're actually attacking.

Right.

You need a mental model of the bacteria.

Yeah.

So just picture a water balloon attached to a running faucet.

The balloon is filling up.

The rubber is stretching.

The pressure is really building.

That's a great analogy.

That is essentially a bacterium trying to survive in the human body.

It has incredibly high internal osmotic pressure.

So imagine poking a tiny hole in that tight rubber.

The pressure is just too much.

The balloon rapidly takes on water.

It swells, bursts and is destroyed.

And when we talk about cephalosporins or carbapenems or vancomycin, that is exactly the goal.

We are poking holes in the bacterial cell wall, causing them to absorb water, burst, which is a process called cell lysis, and basically die.

Which means these drugs are bactericidal, right?

They don't just slow the bugs down, they actively kill them.

Precisely.

So let's start with the most widely used group of antibiotics in the hospital setting, which are the cephalosporins.

Okay.

Structurally, they are incredibly similar to penicillins.

They both have this central chemical structure called a beta -lactam ring.

And that ring is basically the weapon they use to sabotage the bacteria.

So do they just, like, snatch into the cell wall and break it?

Well, it's a bit more insidious than that.

So the bacteria have these specific proteins on their outer surface called penicillin -binding proteins.

PVPs, right?

Yeah, PDPs.

Think of them like the construction workers responsible for building and maintaining the cell wall.

Cephalosporins bind directly to these PVPs.

Just totally tying the hands of the construction workers so they can't build any new wall material?

Exactly.

But the drug does a second thing, which is arguably way more destructive.

By binding to those proteins, the cephalosporins actually trigger the bacteria to release their own auto -license.

Auto -license?

Those are the enzymes bacteria use to break down their own cell walls when they need to divide and grow, right?

Like a remodeling crew?

Right.

So the cephalosporin essentially tricks the bacteria into activating its demolition crew while simultaneously firing its construction crew.

The wall breaks down, no new wall is built, and our water balloon pops.

That is just brutal biological sabotage.

But I mean, obviously bacteria evolve, they don't just sit there and let their walls get demolished.

No, they fight back.

And the main way they resist these drugs is by producing their own defensive enzymes called beta -lactamases.

Which are basically like chemical scissors that specifically target and chop up the beta -lactam ring on the antibiotic.

Exactly.

Rendering the drug completely useless, which, you know, forced pharmaceutical developers to constantly adapt.

When you look at how cephalosporins have evolved over the decades, you can actually trace them through five distinct stages or generations.

I always think of those five generations like smartphone software updates.

Oh, I like that.

Yeah, you start with the first generation, the original clunky model.

And with each new update, the software gets stronger, fixes the bugs of the previous version, and gains these wild new features.

The progression really is very linear.

As you move from the first generation all the way up to the fifth generation, three specific capabilities increase.

Okay, what's the first one?

First, the drug's activity against gram -negative bacteria and anaerobes gets a lot stronger.

Second, its armor improves.

It becomes highly resistant to being chopped up by those beta -lactamase enzymes.

And the third?

Its ability to cross the blood -brain barrier and reach the cerebrospinal fluid, or CSF, increases dramatically.

Okay, let's anchor this with real -world examples so we aren't just talking in the abstract.

First generation, like cephalaxin.

This is your basic model.

It's great for basic gram -positive staph infections on the skin.

But it has terrible armor, so it gets destroyed easily by beta -lactamases, and it definitely cannot reach the brain.

Right.

But then you jump to the third generation, like cefotaxin.

Now you have a drug with a very broad spectrum.

It basically laughs at most beta -lactamases.

And crucially, third -generation agents reach clinically effective concentrations in the CSF.

Exactly.

If you have a patient with bacterial meningitis where the infection is literally in the fluid surrounding the brain and spinal cord, a third -generation cephalosporin is your primary tool.

Awesome.

And then the newest update, the fifth generation,

ceftaraline.

What really justifies creating an entirely new generation just for this one drug?

Well, ceftaraline is the only cephalosporin with activity against MRSA.

Oh, methicillin -resistant staphylococcus aureus.

Yeah.

MRSA has historically altered its penicillin -binding proteins so that standard beta -lactam antibiotics just bounce right off of it.

But ceftaraline is engineered to bind to those mutated PBPs anyway.

That's a massive clinical advantage for resistant skin infections or those really severe healthcare -associated pneumonia.

It really is.

So we have this highly versatile,

incredibly popular class of drugs.

I'm assuming patients are just taking these at home like standard amoxicillin pills, right?

You'd think so, given how common they are, but no.

That is the major catch with cephalosporins.

Your gastrointestinal tract absolutely hates absorbing them.

Really?

Yeah.

If you try to swallow most cephalosporins, they degrade or just pass right through without entering the bloodstream in any meaningful amount.

So for serious systemic infections, they almost entirely have to be administered parenterally.

Meaning for V or I, M.

And once we push them into the patient's veins, how do they get out?

Like they have to be cleared from the body, and because almost all of them are cleared by the kidneys, this creates a pretty major bottleneck.

A bottleneck that nurses have to monitor constantly.

If a patient's kidneys are failing, the drug isn't being excreted, it just builds up in the blood to toxic levels.

So you really have to monitor renal function, specifically looking at creatinine clearance, and anticipate that the provider will need to drastically reduce the dosage for anyone with renal impairment.

Exactly.

But there is a famous exception to this rule.

The one cephalosporin that bypasses the kidneys.

Oh, ceftriaxone.

Yes, ceftriaxone.

It is eliminated largely by the liver, not the kidneys.

Therefore, dosage reduction is completely unnecessary in patients with renal impairment.

So if you have a patient whose kidneys are completely failing, but they desperately need a broad spectrum cephalosporin, ceftriaxone is the safest choice.

Exactly.

And that is the exact kind of nuance that shows up on a pharmacology exam.

Definitely.

Okay, let's talk about what happens when things go wrong.

The adverse effects.

Usually cephalosporins are safe, right?

Yeah, mostly.

The most common issue is just a hypersensitivity reaction, like a maculopapular rash that shows up a few days into treatment.

But because they share that beta -lactam ring with penicillins, the immediate worry is always cross -reactivity.

Like, if my patient is allergic to penicillin, are they going to go into anaphylaxis if I give them a cephalosporin?

The fear is always there, sure.

But the clinical reality is actually much less dramatic.

Only about 1 % of penicillin -allergic patients will experience an allergic reaction if given a cephalosporin.

So if a patient reports a mild penicillin allergy, say they got a little rash a decade ago, cephalosporins can usually be administered with minimal concern.

Right.

However, if the patient has a documented history of severe anaphylactic reactions to penicillin, we are talking airway swelling and shock cephalosporins should be avoided entirely.

Yeah, that 1 % risk is just way too high when the consequence is death.

Exactly.

Now, there is another bizarre side effect tied to three specific cephalosporins—cephatetin, cefzolin, and ceftriaxone.

They can cause a severe bleeding risk.

Yeah, they can.

But why?

Like, how does an antibiotic cause someone to bleed?

It actually comes down to vitamin K.

The human body relies on vitamin K to synthesize prothrombin and other clotting factors.

And a lot of our vitamin K is actually produced by the healthy normal flora living right in our gut.

Oh, so these specific cephalosporins wipe out that gut flora, drastically reducing vitamin K levels.

Yep.

Furthermore, the chemical structure of these three specific drugs actively interferes with

Wow.

So the result is a drop in prothrombin levels, meaning the blood just loses its ability to clot properly.

Which changes the nursing plan of care entirely.

You are suddenly monitoring bleeding times, you're watching for bruising, you might even need to have supplemental vitamin K on hand.

And you'd have to be incredibly conscious if the patient is already taking NSAIDs or blood thinners like warfarin.

Absolutely.

Now there is an even more severe interaction involving cefazolin and cefotetan and it involves alcohol.

It's called a disulfiram -like reaction.

Right.

Disulfiram is the drug given to recovering alcoholics to make them violently ill if they drink.

So these two antibiotics actually mimic that.

They do.

If a patient taking cefazolin or cefotatin ingests alcohol, the antibiotic prevents the breakdown of alcohol in the body.

That leads to a massive, rapid buildup of a toxic compound called acetaldehyde.

So the patient will experience severe flushing, throbbing headaches,

nausea, Kopi's vomiting, sweating, and dangerous hypotension.

It's awful.

So patient education here is absolute.

They cannot consume alcohol in any form, even cough syrups with alcohol while on these medications.

Makes total sense.

Okay, let's shift gears.

Say a patient rolls into the ER with a massive, incredibly complex infection.

It's a mix of aerobic bacteria, anaerobic bacteria, gram positives, gram negatives.

The infection is basically laughing at standard cephalosporins.

Right.

A really bad situation.

What is the next line of defense?

Enter the carbapenems, specifically a drug called imapenem.

Imapenem really is the heavy artillery.

It binds to two specific penicillin -binding proteins, and it is uniquely capable of penetrating the outer envelope of gram -negative bacteria.

And it's highly resistant to practically all beta -lactamases, right?

Yes.

Its antimicrobial spectrum is broader than nearly all other antimicrobial drugs available.

But it doesn't kill everything.

It has a blind spot.

It does.

None of the carbapenems are active against MRSA.

And because imapenem is such a powerful, broad -spectrum weapon,

hospitals have strict stewardship protocols.

So they try to reserve it only for patients with severe, mixed infections who absolutely cannot be treated with a more narrow -spectrum agent.

Exactly.

If we use it for every basic infection, bacteria will develop resistance to it, and we will lose our heavy artillery entirely.

Now there is a really strange detail about how imapenem is supplied.

You never just give imapenem by itself.

It is always packaged in a fixed -dose combination with a chaperone compound called psilostatin.

Why can't imapenem just do its job alone?

This is a masterclass in human biology actively sabotaging drug delivery.

If you infuse imapenem entirely by itself, it travels through the bloodstream and arrives at the kidneys to be filtered.

But humans naturally produce an enzyme in our kidneys called dipeptidase.

And dipeptidase destroys imapenem.

Violently destroys it.

The drug is completely inactivated before it can even reach the urine to be excreted.

Which means urinary levels of the drug are uselessly low.

You could never treat a urinary tract infection with it.

So pharmaceutical scientists literally created a drug to stop our own bodies from destroying the antibiotic.

Exactly.

Psilostatin is a specific dipeptidase inhibitor.

It has absolutely no antibacterial properties whatsoever.

Its only job is to bind to that kidney enzyme and stop it from chewing up the imapenem.

This allows the antibiotic to survive its trip through the kidneys, reach the urine perfectly intact, and actually do its job.

That is fascinating.

Now, while it's saving the day, what kind of collateral damage are we looking at?

The adverse effects are mostly standard GI issues, right?

Nausea, vomiting, diarrhea.

Yes.

But there is a rare, severe risk of seizures.

And that ties into a very specific dangerous drug interaction.

Imapenem drastically reduces the blood levels of valproate, which is a common medication used to control seizure disorders.

Oh, wow.

So if you give imapenem to a patient who has their epilepsy perfectly stabilized on valproate, their seizure medication levels will just plummet.

And they could suffer breakthrough seizures right there in the hospital bed.

If the two drugs absolutely must be used together, the nurse has to anticipate setting up supplemental anti -seizure therapy.

Wow.

Okay.

Well, we spent this entire time talking about drugs that rely on a beta -lactam ring to do their dirty work.

Let's move to the giant of the hospital floor, vancomycin.

Ah, vancomycin.

It does not have a beta -lactam ring, but it is the most widely used antibiotic in US hospitals, primarily because it's the go -to for severe MRSA.

That's right.

But wait, if it doesn't have the beta -lactam ring, how is it popping the water balloon?

Well, if the cephalosporins and carbapenems are jamming the lock by binding to the penicillin -binding proteins, vancomycin is basically hiding the key.

Hiding the key, okay.

It completely ignores the PBPs.

Instead, it binds directly to the structural precursor molecules that the bacteria need to synthesize their cell wall in the first place.

Oh.

So the bacteria go to grab the bricks to build the wall,

and vancomycin has already glued itself to the bricks.

The wall fails, the bacteria swell, and they lies.

Correct.

But because it relies on this highly specific mechanism, vancomycin has a major limitation.

It is strictly for gram -positive bacteria.

Because the gram -negative bacteria have an extra outer membrane that vancomycin is simply too large to cross.

Exactly.

It just physically can't get in.

Which leads us to a huge nursing consideration regarding how we actually get this massive molecule into the patient.

The route of administration changes entirely depending on where the infection is.

Right.

Vancomycin has terrible oral absorption.

If a patient swallows a vancomycin pill, it is not going to cross the intestinal lining and enter the bloodstream in any meaningful amount.

So if you were treating a systemic infection like MRSA in the blood, or a bone infection or endocarditis, it must be administered intravenously.

Yes.

You only ever give vancomycin orally for one specific reason.

Infections of the intestine.

Because if it isn't absorbed into the blood, it just travels right down the GI tract like a bulldozer, directly to where the intestinal infection is.

Exactly.

It stays trapped in the gut, which is precisely what you want if you are treating a severe case of Clostridioids difficile, or C.

diff.

Right.

Let's talk about the dangers of IV vancomycin first, though.

We are mainly worried about two organs.

The ears and the kidneys.

Ototoxicity, meaning hearing loss, is rare but possible, especially if the patient is on other drugs that damage the ears.

But the kidneys really take the beating here.

Renal failure is the major toxicity of vancomycin.

And the damage is highly dose -dependent, right?

Yes.

As a nurse, you are responsible for monitoring serum trough levels.

You draw blood right before the next dose is due to ensure the drug hasn't accumulated too much.

Usually, you are aiming for a trough level of 15 to 20 micrograms per milliliter for serious infections.

You also have to track the patient's serum creatinine.

If the creatinine level increases by 50 % from their baseline, that is a massive red flag indicating significant kidney damage.

And the dosage must be reduced immediately.

Immediately.

There is another intense reaction that happens right at the bedside.

A nurse is hanging a fresh IV bag of vancomycin.

Ten minutes later, the patient is flushed deep red from the neck up.

They have a sprawling rash, they are intensely itchy, their heart rate spikes, and their blood pressure plummets.

It looks exactly like a massive life -threatening allergic anaphylaxis.

It looks terrifying.

But it's not an allergy.

It is known as Redman syndrome, and it is entirely an infusion rate issue.

Right.

When vancomycin is infused rapidly into the bloodstream, it causes the body's mast cells to massively dump histamine.

And that sudden flood of histamine causes the profound vasodilation, the draught in blood pressure, and the intense red flushing.

So the nursing intervention isn't necessarily reaching for an EpiPen, it's reaching for the IV pump.

The crucial intervention is prevention.

You must infuse vancomycin slowly, over an absolute minimum of 60 minutes.

If the patient starts flushing, you stop the infusion, wait for the symptoms to subside, and then restart it at a much slower rate.

Okay, so since we brought up oral vancomycin being used almost exclusively to treat C.

diff, we have to dig a detour here.

Managing C.

diff is a massive part of nursing care.

It really is.

C.

diff is a gram -positive, spore -forming anaerobic bacillus.

It releases two powerful toxins, toxin A and toxin B, that directly attack the lining of the colon.

And symptoms can range from mild, watery diarrhea to a life -threatening condition called toxic

bowel perforation and even death.

What makes C.

diff so frustrating is that, well, we cause it.

Yeah, we do.

C.

diff infections are almost invariably preceded by the use of antibiotics.

A patient comes into the hospital with a standard infection.

We give them clindamycin or maybe a second -generation syphilisporin or a fluoroquinolone.

And those broad -spectrum antibiotics do their job, but they also carpet -bomb the normal healthy flora living in the patient's gut.

Exactly.

And with the good bacteria wiped out, the C.

diff spores, which might have been sitting there completely harmlessly, suddenly have no competition for food or space.

They just flourish.

They multiply rapidly, release their toxins, and suddenly the cure for the initial infection has caused a new, sometimes deadly, intestinal disease.

So the patient is now having three or more unformed stools in 24 hours, and the lab confirms a positive stool test for C.

diff.

What are the Infectious Disease Society of America guidelines telling nurses and providers to actually do?

The very first step is to stop the offending antibiotic that facilitated the overgrowth in the first place, if possible.

Step two is starting an antibiotic that specifically targets C.

diff.

For an initial episode, the preferred therapy is fidexamycin, which is a highly targeted narrow -spectrum macrolide, or our old friend oral vancomycin.

And if the patient crashes into a fulminant, severe case with shock or toxic mega -colon, the guidelines recommend aggressive therapy, like high doses of oral vancomycin combined with IV metronidazole.

There are also newer adjunctive treatments coming out, like bezoltoxamab.

This isn't an antibiotic, it's a monoclonal antibody that physically binds to and neutralizes C.

diff toxin B, which helps prevent the colon damage.

But beyond the medications,

this is a massive infection control issue.

Because C.

diff forms spores.

Spores are basically bacterial escape pods.

They are incredibly resilient, they are resistant to drying out, they survive extreme temperature changes, and most crucially for nurses, they are entirely resistant to alcohol.

Wait, really?

Entirely?

Yes, if you walk out of a C.

diff isolation room and use the alcohol -based hand sanitizer on the wall, you have done absolutely nothing.

You have not killed the spores, they are just sitting perfectly intact on your hands and you will carry them to the next patient's room.

Exactly.

So what breaks down the spore?

Nothing in a standard sink breaks it down, you have to wash your hands vigorously with soap and running water.

The soap doesn't kill the spore either, it's the physical mechanical friction of scrubbing your hands, combined with the running water, that physically dislodges the spores and flushes them down the drain.

And for the patient's room,

standard cleaning wipes completely fail.

You have to use a chlorine -containing agent, like bleach, to actually destroy the spores on bed rails and surfaces.

Soap, friction, water, and bleach, that is frontline nursing right there.

Ok, to wrap up our deep dive into these cell wall wreckers, I want to look at the specialized tools.

Like, what happens when a patient can't take vancomycin, or we need a highly specific sniper instead of a broad -spectrum bomb?

Right, the special cases.

Let's talk about the lipoglycoproteins and the monobactams.

Let's start with the lipoglycoproteins, specifically a drug called televancin.

As the name suggests, it is a synthetic chemical cousin of vancomycin.

But because it was engineered in a lab, it has a dual mechanism of action.

Ok, so like vancomycin, it inhibits bacterial cell wall synthesis.

Right, but it also has a lipid portion that allows it to bind directly to the bacterial cell membrane and disrupt membrane function entirely.

It essentially hits the bacteria with a one -two punch.

It's an incredibly strong alternative, approved for complicated skin infections and ventilator -acquired pneumonia caused by gram -positives, including MRSA.

It is, but because it's in the vancomycin family, I'm assuming it brings along the same baggage, right?

It absolutely does.

Rapid -tooth infusion will trigger the exact same histamine release and Redman syndrome as vancomycin.

And it also carries a significant risk of nephrotoxicity, so baseline and ongoing kidney function tests are totally mandatory.

But because it's a lipoglycoprotein, it introduces some bizarre, unique adverse effects too.

Patients often report severe taste disturbances.

And more alarmingly, their urine can become incredibly foamy.

Foamy urine?

Why?

Because of the lipid properties of the drug.

It essentially acts like a synthetic surfactant, or a soap, as it is filtered through the kidneys.

It's harmless, but it's very alarming for the patient.

A more serious side effect is that televancing can prolong the QT interval on an EKG, disrupting the heart's electrical rhythm.

So you have to be deeply cautious with patients who have underlying heart failure or are taking other QT -prolonging medications.

Yes.

And there is a massive developmental warning attached to televancing.

It carries a severe risk for adverse developmental outcomes in a fetus.

So a serum pregnancy test is required before starting it, and it absolutely must be avoided in pregnant patients.

Definitely a critical point to remember.

Finally, let's look at the sniper.

The monobactams, specifically astreonym.

Monobactams are fascinating chemically.

They have the famous beta -lactam ring, but it's not fused to a second ring like in the penicillins or cephalosporins.

The ring stands entirely alone, hence monobactam.

Ah, that makes sense.

An astreonym binds exclusively to PB3, a specific protein found only in certain bacteria.

Which completely limits its spectrum.

If vancomycin only kills gram -positives, astreonym is the exact opposite.

It is active exclusively against gram -negative aerobic bacteria like Pseudomonas aeruginosa or E.

coli.

It has absolute zero activity against gram -positive bacteria or anaerobes.

It is a highly specialized tool.

And because its chemical structure is a standalone ring, it offers a huge clinical advantage regarding allergies.

It looks so profoundly different from penicillins and cephalosporins that the human organism system rarely recognizes the similarity.

There is almost zero cross -allergenicity.

Meaning, if I have a patient who goes into life -threatening anaphylactic shock when they are exposed to penicillin, I can still safely give them this drug.

Yes.

If you need to treat a severe gram -negative infection in a patient with a known severe penicillin allergy,

astreonym is your vital workaround.

It is generally entirely safe for them.

This all really brings us back to the role of the nurse.

If you are stepping onto the floor for your clinical rotation tomorrow, the core lesson here is that treating bacterial infections isn't just mindlessly hanging IV bags.

No, definitely not.

It requires matching the exact right drug to the right bug, knowing why you don't drop a massive broad -spectrum carbapenem on a basic infection when a narrow first -generation cephalosporin would work perfectly well.

It requires constant vigilance over the patient's renal function, watching the creatinine clearance to ensure the drugs don't build up and destroy the kidneys.

And it requires understanding that the physical speed at which you program the IV pump for vancomycin is the only thing standing between your patient healing quietly or suffering a severe, terrifying histamine reaction.

It really is a constant high -stakes balancing act.

And I think the section on C.

diff and the broad -spectrum carbapenems leaves us with a critical thought on the concept of antibiotic stewardship.

Yeah, that's a huge takeaway.

We spend years learning how these miraculous chemical structures destroy cell walls, how they disrupt penicillin -binding proteins, all to save human lives.

But considering that these exact same life -saving drugs can cause life -threatening C.

diff by destroying our normal, healthy gut flora.

At what point does the cure become the disease?

Next time you hang an IV bag of a broad -spectrum antibiotic, ask yourself what invisible, protective ecosystem you might be disrupting in the process.

We are destroying the wall to save the patient, but we might be destroying their ecosystem, too.

It's exactly like that water balloon.

Once you pop it, you really can't control where all the water goes.

You really can't.

Thank you for studying with us from the Last Minute Lecture Team.

Good luck on your exams, and we'll see you next time.